1417 (1417) Fair Value & Analysis

Real Estate · Market cap HK$1.4B

1 1417 1417 · HK

PriceHK$3.20

Fair ValueHK$0.4800

Upside-85.0%

Quality58/100

Watch 1417 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.2000 – HK$0.7600

Fair value as of: Jul 2, 2026

From 9 valuation models · updated today

Share price +85.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1834 – HK$3.21 · fair‑value band HK$0.2000 – HK$0.7600 · the HK$3.20 price screens above the HK$0.4800 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1417 (1417) currently trades at HK$3.20, while our model-based Fair Value estimate is HK$0.4800 — implying the stock looks roughly 85.0% overvalued today. We read business quality at 58/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1417 generated revenue of HK$1.1B at a net margin of -2.3%. Revenue grew 9.6% year over year. It earns a return on equity of -7.7%. Net debt stands at HK$257M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.1B

Revenue growth (YoY) +9.6%

Net margin -2.3%

Return on equity -7.7%

Free cash flow HK$2.7M FY2025

Operating margin 0.7%

More key figures

EPS growth (YoY) +690%

Net debt HK$257M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1417 reported revenue of HK$1.1B in FY2025 versus HK$886M in FY2021, a compound +5.0%/yr. Reported net income was −HK$25.0M in FY2025.

Revenue +5.0%/yr

FY21 HK$886M

FY22 HK$918M

FY23 HK$920M

FY24 HK$967M

FY25 HK$1.1B

Net income

FY21 HK$38.6M

FY22 HK$12.5M

FY23 −HK$74.5M

FY24 −HK$50.3M

FY25 −HK$25.0M

Is 1417 fairly valued? → Check now

Similar stocks

6 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Vingroup Joint Stock Company VIC	219,800 VND	33,299 VND	-85%
CBRE Group CBRE	$129.95	$78.11	-40%
2423 2423	HK$38.90	HK$17.91	-54%
1972 1972	HK$20.40	HK$18.75	-8%
1209 1209	HK$36.68	HK$34.70	-5%
Plaza S.A MALLPLAZA	3,800 CLP	5,905 CLP	+55%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1417 (1417) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.4800 versus a price of HK$3.20 — about −85% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1417?

Our model-based fair value for 1417 is HK$0.4800 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$3.20.

What is the quality score of 1417?

1417 has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1417 (1417)?

1417 reported trailing-twelve-month revenue of about HK$1.1B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1417?

The net profit margin of 1417 is about -2.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.